Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Stimcell EnergeticsSTME +25.18%27 EV-to-OCF is -24.93 as of Aug. 09, 2026. GuruFocus rates STME with a GF Score™ of 27/100. The stock has 4 warning signs investors should review. Among 853 Medical Devices & Instruments companies, Stimcell Energetics ranks better than 89.33% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Stimcell Energetics's Enterprise Value is $8.13 Mil.
Stimcell Energetics's Cash Flow from Operations for the trailing twelve months (TTM) ended in Feb. 2026 was $-0.33 Mil. Therefore, Stimcell Energetics's EV-to-OCF for today is -24.93.
The historical rank and industry rank for Stimcell Energetics's EV-to-OCF or its related term are showing as below:
STME'
s EV-to-OCF Range Over the Past 10 Years
Min: -121.52 Med: -10.78 Max: -3.13
Current: -24.93
During the past 13 years, the highest EV-to-OCF of Stimcell Energetics was -3.13. The lowest was -121.52. And the median was -10.78.
STME's EV-to-OCF is ranked better than 89.33% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 7.82
vs STME: -24.93
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Stimcell Energetics's PE Ratio (TTM) for today is calculated as:
Stimcell Energetics's share price for today is $0.348.
Stimcell Energetics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.030.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Stimcell Energetics EV-to-OCF Related Terms
Stimcell Energetics EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Stimcell Energetics's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Stimcell Energetics's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Stimcell Energetics EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Stimcell Energetics's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Stimcell Energetics's EV-to-OCF falls into.
Stimcell Energetics's current Enterprise Value is $8.13 Mil.
Stimcell Energetics's Cash Flow from Operations for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.33 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Stimcell Energetics (STME) has a EV-to-OCF of -24.93 as of Aug. 09, 2026. According to the industry distribution chart, Stimcell Energetics ranks #91 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 10.7%.
Is Stimcell Energetics' EV-to-OCF too high?
Stimcell Energetics' current EV-to-OCF is -24.93. Based on the distribution chart, Stimcell Energetics ranks #91 out of 853 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Stimcell Energetics has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Stimcell Energetics' EV-to-OCF compare to TRIB and AIDX?
According to the Medical Devices & Instruments industry distribution chart, Stimcell Energetics ranks #91 out of 853 companies for EV-to-OCF. This places Stimcell Energetics in the top 11% of its industry — outperforming the majority of peers. The industry median EV-to-OCF is 7.82. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.82, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Stimcell Energetics's current EV-to-OCF is -24.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stimcell Energetics stock overvalued right now?
Stimcell Energetics (STME) has a current EV-to-OCF of -24.93. The current EV-to-OCF is -24.93. Stimcell Energetics' overall GF Score™ is 27/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Stimcell Energetics (STME), the current EV-to-OCF is -24.93 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Stimcell Energetics Inc is a biotech company focused on the discovery, development, and commercialization of therapeutic and non-therapeutic products that enhance cellular function, promote general wellness, and alleviate health complications, including, but not limited to: aging, diabetes, high blood pressure, neuropathy, and kidney function. The company's main focus is on continued research and development of its eBalance Technology and its eBalance Home System.
27GF Score
Get the complete analysis for STME
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STME has been successfully added to your 
